abstract |
The present invention relates to nucleic acid constructs comprising adenovirus E2 late promoters or fragments thereof and nucleic acids. The nucleic acid is selected from a group of transgenes, genes and nucleic acids, each different from an adenovirus nucleic acid regulated by an E2 late promoter. The invention also relates to the use of such nucleic acid constructs. |